Picture of Orchid Pharma logo

ORCHPHARMA — Orchid Pharma News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Orchid Pharma Receives Dcgi Approval For Antibiotic Drug Combination Of Cefepime, Enmetazobactam

June 6 (Reuters) - Orchid Pharma Ltd  ORCD.NS :
    * RECEIVES DCGI APPROVAL FOR ANTIBIOTIC DRUG COMBINATION OF
CEFEPIME AND ENMETAZOBACTAM
    * APPROVAL PAVES WAY FOR LAUNCH OF INJECTABLE THERAPY FOR
PATIENTS
IN INDIA
    * PERMISSION ALSO TO MANUFACTURE FINISHED DOSAGE FORM OF
CEFEPIME,
ENMETAZOBACTAM AS DRY POWDER INJECTABLE

Source text for Eikon:  ID:nBSE6Vcg9s 
Further company coverage:  ORCD.NS 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Orchid Pharma

See all news